Senior Scientist, Early Development Group
- Experience Level
- Experienced (non-manager)
Oxford BioMedica is a pioneer of gene and cell therapy and our work is helping to deliver life changing treatments.
Gene and cell therapy is the treatment of disease by the delivery of therapeutic DNA into a patient’s cells, providing long term and potentially curative treatments for a wide range of diseases. With the potential to transform medicine, the sector holds significant promise with the first commercial products now launched and others rapidly approaching the market.
We are currently looking to recruit a Senior Scientist within our Early Development Group. Oxford Biomedica’s Preclinical Studies Group is expanding its therapeutic portfolio and looking to recruit an experienced scientist to support the development of our preclinical programme. The Preclinical Studies Group manages a portfolio of projects which are conducted with CROs and academic collaborators. The Company has a platform of exclusive and pioneering technologies on which are designed, developed and manufactured unique gene- and cell-based medicines.
We are looking for a highly motivated and skilled scientist with particular experience in preclinical testing in animal models of disease and/or viral vectored gene therapies to work within our dynamic, research-orientated group. In this office based role, the successful candidates will be involved in:
- Managing preclinical studies to test gene therapy products for therapies currently under development.
- Initiating and developing new studies
- Identifying and developing new disease targets for our gene therapy products.
Key skills and requirements:
- PhD or equivalent in relevant bioscience (e.g. virology, molecular and/or cellular biology) and have several years’ post-doctoral experience in academia or industry demonstrated by a strong publication record.
- Experience working with animal models of disease
- Demonstrated ability to manage and execute projects to aggressive timelines with the ability to adapt to rapid changes in project priorities.
- Excellent written and verbal communication skills.
- Excellent organisational and time management skills.
- Good attention to detail.
- Highly motivated.
- Expertise in lentiviral vector gene therapies a distinct advantage.
Key responsibilities and accountabilities:
- Lead/manage preclinical research in the disease pipeline.
- Development of new targets for gene therapy.
- Independently manage daily research activities and support junior members of staff.
- Support other members of the group and wider the Research Group as required.
- Knowledge and experience of animal models of disease and/or viral vector based therapies.
- Knowledge and experience in one of the following areas would be an advantage: neurology, ocular and oncology.
- A highly motivated, enthusiastic, positive attitude.
- Ability to demonstrate (by peer-reviewed publications) the ability to work independently and with a good understanding of the field they are working within.
- Ability to work well in a team setting and when appropriate, ensure others are able to perform the tasks to the benefit of the team’s objectives.
No agencies please